Merck KGaA 1Q Earnings, Sales Rise
May 12 2021 - 1:56AM
Dow Jones News
By Cecilia Butini
Merck KGaA said Wednesday that earnings and revenue rose in the
first quarter, driven by all its business division but especially
life science.
After-tax profit at the German pharmaceuticals-and-chemicals
company came in at 748 million euros ($908.9 million) for the
quarter, up from EUR458 million in the same quarter a year
prior.
Earnings before interest, taxes, depreciation and amortization
before one-time items, or Ebitda pre, stood at EUR1.51 billion,
compared with EUR1.18 billion in the first quarter of 2020, as the
company had communicated in a preliminary statement on May 4.
Net sales came in at EUR4.63 billion, up from EUR4.37 billion,
which had also already been communicated in a preliminary
statement.
For the full year, sales are expected to come in between EUR18.5
billion and EUR19.5 billion, a guidance increase that had been
previously communicated in a preliminary statement. Ebitda pre is
seen coming in between EUR5.4 billion and EUR5.8 billion, the
company said. That compares with a previous guidance of strong
organic growth.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
May 12, 2021 01:41 ET (05:41 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Merck KGAA (TG:MRK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Merck KGAA (TG:MRK)
Historical Stock Chart
From Sep 2023 to Sep 2024